CostaR. Unscheduled Return Visits to the Emergency Department after Cardiac Electronic Devices Implantation. Arq. Bras. Cardiol. 2019;112(5):499-500.
Costa,Roberto. Unscheduled Return Visits to the Emergency Department after Cardiac Electronic Devices Implantation. Arq. Bras. Cardiol., v. 112, n. 5, p. 499-500, May. 2019.
Costa,R. (2019). Unscheduled Return Visits to the Emergency Department after Cardiac Electronic Devices Implantation. Arq. Bras. Cardiol.,112(5), 499-500.
Costa,Roberto. Unscheduled Return Visits to the Emergency Department after Cardiac Electronic Devices Implantation. Arq. Bras. Cardiol. [online]. 2019, vol. 112, n. 5, [cited 2025-09-08], pp.499-500. Available from: <https://abccardiol.org/en/short-editorial/unscheduled-return-visits-to-the-emergency-department-after-cardiac-electronic-devices-implantation/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.